We use cookies to optimize your experience, analyze traffic, and personalize ads. Please choose whether you accept our use of non-essential cookies. Read More
Mentis Care is a joint venture between SK Biopharmaceuticals and Eurofarma, formed to expand neurological care beyond pharmaceuticals through emerging digital technologies.
The company builds on the partners’ understanding of clinical practice, patient experience, and the healthcare ecosystem, with a shared commitment to advancing neurological understanding through responsible, evidence-driven innovation.
To build an intelligent, clinically validated platform that detects and predicts seizures and other neurological events, delivers real-time insight, enhances patient safety, supports clinicians, and creates a foundation for a new era of predictive neurological care.
A world where neurological disorders no longer restrict human potential, where predictive AI empowers people to live with freedom, confidence, and stability. Mentis Care envisions a future in which advanced brain-health technology is accessible, trusted, and seamlessly integrated into everyday care.
At Mentis Care AI, our work is powered by a team of doctors, researchers, engineers, and clinicians united by one goal: Making neurological care safer and more effective.
Coming Soon!
Hassan Kotob
CEO
Lorem Ipsum
Sed do eiusmod
Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam.
Hassan Kotob
Chief Executive Officer
Hassan Kotob has 30+ years of leadership building and transforming tech-enabled companies. As CEO of Mentis, he leverages expertise in founding enterprises, navigating FDA regulations, forging global partnerships, and driving shareholder value through successful exits. Previously, he led Piezo Motion & Brain Scientific through a strategic merger and public listing and built North Plains Systems into a global leader in Digital Asset Management. Earlier, as CEO of Medasys, he pioneered PACS imaging systems, formed a key alliance with Hitachi, and took the company public.
Fred Anthony
Chief Technology Officer
Fred Anthony has 25+ years in software engineering, AI innovation, and MedTech. At Mentis, he leads technology strategy, clinical-grade software, EEG infrastructure, and device development. Previously, he secured FDA clearance for Brain Scientific’s EEG headset and held CTO roles at multiple tech firms. Fred excels at aligning teams and translating AI into patient-centered solutions.
Dr. Samaneh Nasiri
Chief Scientific Advisor
Dr. Nasiri is an AI and neurophysiology researcher with 15+ years in EEG, multimodal signal processing, and deep learning. Her work focuses on scalable models for electrophysiology and foundation architectures. She held faculty roles at Harvard Medical School and Emory University, contributing to major neurophysiology initiatives. Beyond academia, she has collaborated with Apple, Microsoft, Google X, and LifeBell AI to translate AI models into real-world applications.
Dr. Eliezer Sternberg
Medical Advisor
Eliezer Sternberg, M.D. is a board-certified neurologist specializing in seizures and epilepsy. He is chairman of the Department of Medicine and chief of Neurology at Milford Regional Medical Center in Massachusetts, and Assistant Professor of Neurology at the UMass Chan School of Medicine. He trained at Tufts, Yale-New Haven Hospital, and Harvard’s Massachusetts General Hospital. He has written for general audiences in The Washington Post and The Wall Street Journal, and is the author of three books on the brain, including NeuroLogic.
Minna Lin
Chief Financial Officer
Minna Lin has over 12 years of experience in SME and Corporate accounting. At Mentis, she leads finance, accounting, and forecasting as a fractional CFO from Welch LLP. Previously, she served as Controller at Exzell Pharma and has served as Accounting Manager in businesses across various industries. She holds a CPA in Ontario and studied Accounting & Finance at Seneca Polytechnic.
Jeremy Sohn
Senior Advisor
Jeremy Sohn is a PE/VC/Private Credit investor, entrepreneur, and former pharma executive. He founded P74 Capital in 2022 to de-risk life sciences investing. At Novartis, he led global digital BD&L, partnerships, and innovation, driving AI/ML strategy, digital biomarkers, prescription digital therapeutics, and digital health programs. Previously, he founded and invested in health-tech startups including TriNetX (acquired by Carlyle) and CentrosHealth (acquired by Clinical Ink).
Seunglee Park
Regulatory and Compliance Lead
Seunglee Park has 15+ years of regulatory and quality experience in medical devices. At Mentis, he directs global regulatory strategy, quality systems, and compliance. Previously, at Samsung Healthcare, Lunit, and SK Biopharmaceuticals, he led clinical approvals and regulatory clearances across the US, Europe, China, and Brazil, and built quality systems certified to ISO 13485, MDSAP, and EU MDR. He holds a B.S. in Biomedical Engineering from Yonsei University.
Sean Stewart
Chief of Staff & Operations
Sean Stewart has 8 years of experience in strategy and operations, turning ambitious vision into disciplined execution in startup leadership and advisory positions. At Mentis, he works with the CEO and rest of the executive team to align strategic priorities, lead cross-functional initiatives, and keep the company scaling efficiently. Previously, he served as Sr. Manager of Strategy & Operations at EMIR, Chief of Staff at Brain Scientific, and Consultant at Altman Solon. He holds a B.S. in Economics from Duke University.